GGrantIndex
← Leaderboards

Ayad A Jaffa

Medical University Of South Carolina

$7,063,873
Attributed
$7,254,109
Total exposure
8
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $682.7K · FY200521
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$7,254,109 · 8

By mechanism

R01$6,294,420 · 4
T35$402,007 · 1
R21$380,473 · 1
P01$131,091 · 1
R29$46,118 · 1

Top collaborators

Most similar at Medical University Of South Carolina

Same institution · by research overlap

Others in their field

Top investigators on “Diabetes Mellitus

Research focus

Diabetes MellitusHyperglycemiaHypertensionMacrovascular DiseaseBaseRisk FactorsKidney DiseasesCohortSignal TransductionBlood VesselsDiabeticPlayVascular DiseasesExcretory FunctionLinkCardiovascular Risk FactorAlbuminuriaAlbuminsDiabetic AngiopathiesMeasurementTrendLipidsResponseComplications Of Diabetes Mellitus

Grant awards (29)

Building Infrastructure to Address Social, Cultural and Biological Determinants of Diabetes in Lebanon$189,745
R21 · FY2021 · TW · contact PI
Building Infrastructure to Address Social, Cultural and Biological Determinants of Diabetes in Lebanon$190,728
R21 · FY2020 · TW · contact PI
MECHANISMS OF VASCULAR DISEASE IN DIABETES$416,718
R01 · FY2017 · HL · contact PI
MECHANISMS OF VASCULAR DISEASE IN DIABETES$416,718
R01 · FY2016 · HL · contact PI
MECHANISMS OF VASCULAR DISEASE IN DIABETES$410,467
R01 · FY2015 · HL · contact PI
MECHANISMS OF VASCULAR DISEASE IN DIABETES$373,798
R01 · FY2014 · HL · contact PI
KALLIKREIN AND VASCULAR DISEASE RISK IN DIABETES$313,210
R01 · FY2011 · HL · contact PI
LIPOPROTEINS, CTGF AND DIABETIC VASCULAR & RENAL DISEASE$354,415
R01 · FY2010 · HL · contact PI
KALLIKREIN AND VASCULAR DISEASE RISK IN DIABETES$310,045
R01 · FY2010 · HL · contact PI
LIPOPROTEINS, CTGF AND DIABETIC VASCULAR & RENAL DISEASE$354,415
R01 · FY2009 · HL · contact PI
KALLIKREIN AND VASCULAR DISEASE RISK IN DIABETES$316,373
R01 · FY2009 · HL · contact PI
LIPOPROTEINS, CTGF AND DIABETIC VASCULAR & RENAL DISEASE$354,415
R01 · FY2008 · HL · contact PI
KALLIKREIN AND VASCULAR DISEASE RISK IN DIABETES$328,248
R01 · FY2008 · HL · contact PI
LIPOPROTEINS, CTGF AND DIABETIC VASCULAR & RENAL DISEASE$354,415
R01 · FY2007 · HL · contact PI
Short Term Research Training for Health Professional St*$46,687
T35 · FY2007 · DK · contact PI
LIPOPROTEINS, CTGF AND DIABETIC VASCULAR & RENAL DISEASE$365,000
R01 · FY2006 · HL · contact PI
Short Term Research Training for Health Professional St*$46,599
T35 · FY2006 · DK · contact PI
KININS ROLE IN MESANGIAL CELL FIBROSIS$250,250
R01 · FY2005 · DK
Short Term Research Training for Health Professional St*$106,054
T35 · FY2005 · DK
KININS ROLE IN MESANGIAL CELL FIBROSIS$250,250
R01 · FY2004 · DK
SHORT-TERM TRAINING IN HEALTH PROFESSIONAL SCHOOLS$116,504
T35 · FY2004 · DK
KININS ROLE IN MESANGIAL CELL FIBROSIS$250,250
R01 · FY2003 · DK
SHORT-TERM TRAINING IN HEALTH PROFESSIONAL SCHOOLS$86,163
T35 · FY2003 · DK
KALLIKREINS-KININS AND DIABETIC VASCULAR COMPLICATIONS$317,920
R01 · FY2002 · HL
KININS ROLE IN MESANGIAL CELL FIBROSIS$250,250
R01 · FY2002 · DK
KININS ROLE IN MESANGIAL CELL FIBROSIS$307,263
R01 · FY2001 · DK
KALLIKREIN-KININ SYSTEM AND DIABETIC COMPLICATIONS$73,467
P01 · FY2001 · HL
KALLIKREINS AND KININS IN DIABETIC VASCULAR DISEASE$57,624
P01 · FY2000 · HL
KININS ROLE IN MESANGIAL CELL PROLIFERATION$46,118
R29 · FY2000 · DK